With clinical trial protocols becoming ever more complex, it can feel like it’s never been more difficult to find patients who are both eligible for and interested in a particular clinical trial. Traditional methods of recruitment are becoming less impactful, which is why it’s time to consider a new approach: precision recruitment.
Yesterday, Antidote’s Director of Business Development, Rachel Lind, hosted a webinar on precision recruitment. She discussed current methods of outreach and outlined the elements of precision recruitment, focusing on the ways in which this approach can address the difficulties of modern recruitment. She also took questions on the way Antidote works with labs, sites, and advocacy groups, as well as on our approach to patient registries.
You can view a recording of the webinar below:
If you’d like to learn more, you can also download a white paper on precision recruitment below.